Long-term safety of lentiviral or gammaretroviral gene-modified T cell therapies. - Jadlowsky JK; Hexner EO; Marshall A; Grupp SA; Frey NV; Riley JL; Veloso E; McConville H; Rogal W; Czuczman C; Hwang WT; Li Y; et al. (Nature medicine, 2025)